| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 08/09/2001 | CA2399026A1 Mucin-1 derived antigens and their use in immunotherapy |
| 08/09/2001 | CA2399022A1 Ligand for vascular endothelial growth factor receptor |
| 08/09/2001 | CA2398998A1 Cd40-binding apc-activating molecules |
| 08/09/2001 | CA2398995A1 Lipid hydrolysis therapy for atherosclerosis and related diseases |
| 08/09/2001 | CA2398889A1 Antisense modulation of survivin expression |
| 08/09/2001 | CA2398877A1 Nucleic acids, proteins, and antibodies |
| 08/09/2001 | CA2398816A1 Human immunodeficiency virus vaccine |
| 08/09/2001 | CA2398678A1 Selective killing of cells by activation of double-stranded rna dependent protein kinase-pkr |
| 08/09/2001 | CA2398255A1 Bcl-2-like polynucleotides, polypeptides, and antibodies |
| 08/09/2001 | CA2398215A1 Methods and materials relating to preadipocyte factor-1-like (pref-1-like) polypeptides and polynucleotides |
| 08/09/2001 | CA2398172A1 Synthesis of spatially addressed molecular arrays |
| 08/09/2001 | CA2398168A1 Polynucleotide arrays and their use in sequencing |
| 08/09/2001 | CA2396774A1 Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon |
| 08/09/2001 | CA2391209A1 Root transcriptional factors and methods of use |
| 08/09/2001 | CA2369742A1 Methods of generating protein expression arrays and the use thereof in rapid screening |
| 08/08/2001 | EP1122540A2 Method for production of a test surface for use in optical detection of a biological binding event |
| 08/08/2001 | EP1122539A2 Method for production of a test surface for use in optical detection of a biological binding event |
| 08/08/2001 | EP1122318A2 Diagnostic method for the detection of polymorphisms related to the human urokinase plasminogen activator receptor |
| 08/08/2001 | EP1122316A1 Process for obtaining transgenic plants which have an improved capacity for the uptake of nutrients and tolerance to toxic compounds which are presents in the soil |
| 08/08/2001 | EP1122315A1 Corynebacterium aquaticum levodione reductase gene |
| 08/08/2001 | EP1122314A1 Method for the production of a protein |
| 08/08/2001 | EP1122313A1 Novel g protein-coupled receptor protein and dna thereof |
| 08/08/2001 | EP1122312A1 Novel protein war-1 and gene thereof |
| 08/08/2001 | EP1122311A1 Remedies for neuropathy containing as the active ingredient galectin-1 or its derivatives |
| 08/08/2001 | EP1122308A1 Method for amplifying foreign gene |
| 08/08/2001 | EP1122306A1 Novel deoxyribonuclease, gene encoding the same and use thereof |
| 08/08/2001 | EP1121600A2 Method and substances for diagnosis and therapy of sepsis and sepsis-like systemic infections |
| 08/08/2001 | EP1121599A1 Detection and quantification of vancomycin in biological fluids |
| 08/08/2001 | EP1121596A1 Microarray system and process for performing biochemical reactions |
| 08/08/2001 | EP1121593A2 Method for extracting quantitative information relating to an influence on a cellular response |
| 08/08/2001 | EP1121470A1 Methods for manipulating complex nucleic acid populations using peptide-labeled oligonucleotides |
| 08/08/2001 | EP1121468A1 Metabolic selection methods |
| 08/08/2001 | EP1121464A1 Polymorphism in a tgf-ss gene correlated to osteoporosis |
| 08/08/2001 | EP1121463A1 Improved hybridisation assay in which excess probe is destroyed |
| 08/08/2001 | EP1121462A2 Genes for assessing cardiovascular status and compositions for use thereof |
| 08/08/2001 | EP1121461A1 Fluorescent probes for chromosomal painting |
| 08/08/2001 | EP1121460A1 Methods and means for isolating and purifying nucleic acids on surfaces |
| 08/08/2001 | EP1121459A2 Color compensation for temperature and electronic gains |
| 08/08/2001 | EP1121455A1 Zinc finger peptide cleavage of nucleic acids |
| 08/08/2001 | EP1121454A1 Extracellular novel rage binding protein (en-rage) and uses thereof |
| 08/08/2001 | EP1121452A1 Transformation process |
| 08/08/2001 | EP1121451A1 Method for obtaining transgenic plants expressing a protein with activity producing hydrogen peroxide by transformation by agrobacterium rhizogenes |
| 08/08/2001 | EP1121450A1 Improved method for more efficient electroporation |
| 08/08/2001 | EP1121449A1 Delivery system for porcine somatotropin |
| 08/08/2001 | EP1121448A1 EXPRESSION AND SECRETION OF icIL-1 RECEPTOR ANTAGONIST TYPE II |
| 08/08/2001 | EP1121447A2 Means and methods for modulating stomata characteristica in plants |
| 08/08/2001 | EP1121446A1 Aminoacylase and its use in the production of d-aminoacids |
| 08/08/2001 | EP1121445A2 Specific genetic modification of the activity of trehalose-6-phosphate synthase and expression in a homologous or heterologous environment |
| 08/08/2001 | EP1121444A2 Protein kinase homologs |
| 08/08/2001 | EP1121443A1 Plant promoter |
| 08/08/2001 | EP1121442A2 Recombinant e1a deleted adenoviral vectors |
| 08/08/2001 | EP1121441A2 Selectively replicating viral vectors |
| 08/08/2001 | EP1121440A2 Improved expression of cry3b insecticidal protein in plants |
| 08/08/2001 | EP1121439A2 Methods and compositions for inhibiting neoplastic cell growth |
| 08/08/2001 | EP1121438A2 p53 BINDING AREAS |
| 08/08/2001 | EP1121437A2 Metastatic breast and colon cancer regulated genes |
| 08/08/2001 | EP1121436A2 Non-desensitizing ampa-receptors |
| 08/08/2001 | EP1121435A1 Camel, an alternative translation product of the tumour antigen lage-1 |
| 08/08/2001 | EP1121434A1 A method of modulating cell survival and reagents useful for same |
| 08/08/2001 | EP1121433A2 Human ankyrin family protein |
| 08/08/2001 | EP1121432A2 G-protein-coupled receptor-like proteins, polynucleotides encoded by them, and methods of using same |
| 08/08/2001 | EP1121431A1 Non-endogenous, constitutively activated human g protein-coupled receptors |
| 08/08/2001 | EP1121430A1 Human isre-binding protein |
| 08/08/2001 | EP1121429A2 Gene therapy of alzheimer's disease by delivery of an encoded apolipoprotein e |
| 08/08/2001 | EP1121428A2 Genes, proteins and biallelic markers related to central nervous system disease |
| 08/08/2001 | EP1121427A1 (mbp1) polypeptides capable of interacting with oncogenic mutants of the p53 protein |
| 08/08/2001 | EP1121426A2 Method for triggering apoptosis in cells |
| 08/08/2001 | EP1121425A1 Stabilized bioactive peptides and methods of identification, synthesis and use |
| 08/08/2001 | EP1121422A2 Terpene synthases |
| 08/08/2001 | EP1121421A1 Materials and methods for the modification of plant lignin content |
| 08/08/2001 | EP1121419A1 Tnfr related gene 12 |
| 08/08/2001 | EP1121383A1 Methods for the production of antibodies to specific regions of cyclosporine and cyclosporine metabolites |
| 08/08/2001 | EP1121382A2 Interferon-beta fusion proteins and uses |
| 08/08/2001 | EP1121381A2 Zinc finger binding domains for gnn |
| 08/08/2001 | EP1121379A1 MAMMALIAN elk POTASSIUM CHANNEL GENES |
| 08/08/2001 | EP1121374A1 Bone morphogenic protein-induced genes and polypeptides, and their use in diagnostic and therapeutic methods |
| 08/08/2001 | EP1121373A2 Immunostimulatory oligonucleotides with modified bases and methods of use thereof |
| 08/08/2001 | EP1121371A1 Nucleotide compounds including a rigid linker |
| 08/08/2001 | EP1121157A1 A novel component in the hedgehog signalling pathway |
| 08/08/2001 | EP1121155A2 Site-directed dual pegylation of proteins |
| 08/08/2001 | EP1121150A1 Delta 6 fatty acid desaturase |
| 08/08/2001 | EP1121140A2 Method for screening for anti-amyloidogenic properties and method for treatment of neurodegenerative disease |
| 08/08/2001 | EP1121137A1 Method for killing tumor and tumor associated endothelial cells using adenoviral mutants |
| 08/08/2001 | EP1054595A4 Methods and compounds for the genetic treatment of hyperlipidemia |
| 08/08/2001 | EP0960118A4 Nucleotide and protein sequences of liver activin/inhibin and methods based thereon |
| 08/08/2001 | EP0871776A4 A novel human b cell surface molecule |
| 08/08/2001 | EP0842430B1 Herpes simplex virus diagnostics |
| 08/08/2001 | EP0820463A4 Igf-i purification process |
| 08/08/2001 | EP0815133A4 Human stat4 |
| 08/08/2001 | EP0786004B1 Cloning, expression and characterisation of a novel form of phosphatidylinositol-3-kinase |
| 08/08/2001 | EP0726949B1 Opioid receptor: compositions and methods |
| 08/08/2001 | EP0689587A4 Mutant luciferases |
| 08/08/2001 | EP0672149B1 PROCESS FOR PRODUCING/SECRETING A PROTEIN BY A TRANSFORMED MOULD USING EXPRESSION/SECRETION REGULATING REGIONS DERIVED FROM AN $i(ASPERGILLUS) ENDOXYLANASE II GENE |
| 08/08/2001 | EP0669829B1 Enhancement of xenograft tolerance and porcine cytokines therefor |
| 08/08/2001 | CN1307644A Primers for detection of spore forming bacteria in paper products and paper manufacturing streams |
| 08/08/2001 | CN1307643A Human BMP-7 promoter and method for exploring bone-related substance by using the same |
| 08/08/2001 | CN1307642A Method for producing polypeptide by modifying copy number of gene |
| 08/08/2001 | CN1307641A DSRNA-mediated regulation of gene expression in plants |
| 08/08/2001 | CN1307640A Cell separation device and separation method |
| 08/08/2001 | CN1307639A Pesticidal toxins and nucleotide sequences which encode there toxins |